Sionna Stock 144% This Year: Is the Biotech a Buy Now?
Sionna Therapeutics has surged 144% over the past year, drawing attention from growth-minded investors. This article ...
Uncover Ways To Visualize Financial Goal Progress with charts and visuals that make progress tangible, boosting motivation and consistency.
21,483 articlesSionna Therapeutics has surged 144% over the past year, drawing attention from growth-minded investors. This article ...
Meta Platforms is ending Horizon Worlds as a standalone VR social platform and redirecting capital to AI infrastructu...
Oil markets remain volatile amid geopolitical risk, but three U.S. majors are drawing attention for potential 50%+ re...
UBS lifts industries $140 price target on CF Industries as nitrogen markets tighten amid supply disruptions. The move...
Coinbase soared about 12% in trading after Sen. Lummis announced a bipartisan deal on the Clarity Act for stablecoin ...
A federal trade court has struck down a second round of tariffs ordered during the Trump administration. The decision...
As Zebra Technologies previews its Q1 2026 results, investors weigh hardware demand, software subscriptions, and marg...
This deep-dive breaks down accelerant (arx) 2026 earnings, translating the Q1 transcript into actionable takeaways. L...
The White House announced that China will buy a minimum of $17 billion in U.S. agricultural goods each year through 2...
Intel stock climbs about 5% after word that the company is in talks to acquire AI accelerator startup Tenstorrent, re...
Five years after a regulatory shock hit XRP, a $10,000 investment would have swung through a volatile ride. Here’s th...
Global stocks drift higher as talks on a U.S.-Iran peace deal gain momentum. Yet traders warn the market isn’t fully ...